Reply to the letter to the editor 'Potential clinical relevant drug-drug interactions: comparison between different compendia, do we have a validated method?' by Conde-Estevez et al.

被引：1

作者：

van Leeuwen, R. W. F. ^{[1
,2
]}

Mathijssen, R. H. J. ^{[2
]}

Jansman, F. G. A. ^{[3
,4
]}

van Gelder, T. ^{[1
,5
]}

机构：

[1] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands

[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands

[3] Deventer Hosp, Dept Clin Pharm, Deventer, Netherlands

[4] Univ Groningen, Groningen, Netherlands

[5] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands

来源：

关键词：

CANCER; PREVALENCE;

D O I：

10.1093/annonc/mdv169

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1272 / 1273

页数：3